Resverlogix Corp.

TSX Exchange | Oct 18, 2019, 2:41 PM EDT | Real-time price

RVX $ 1.44 RT
-0.04 (-2.7027%)
Day Low: 1.33
Day High: 1.54
Detailed Quote
Open: 1.54
High: 1.54
Beta: -0.06067
Listed Shares Out.1: 209,420,046
Total Shares (All Classes)2: 209,154,455
Prev. Close: 1.48
Low: 1.33
VWAP: 1.4463
Market Cap1: 301,564,866
Market Cap (All Classes)2*: 301,182,415
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.79
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -1.171
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases. More

News Headlines for Resverlogix Corp.
News Headlines for Resverlogix Corp.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.